Pharmaceutical Sector Report 2023 – Addressing health disparities, one innovation at a time

Highlights of the report

The adoption of new treatments remains a key driver of growth in the pharmaceutical market. However, the industry faces challenges such as patent lifecycles and increasing competition from generic and biosimilar drugs. These factors will continue to influence medicine spending and overall market growth.

Why Crispidea Report

This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

Industry Analysis

Developed economies with established healthcare systems and substantial levels of per capita healthcare spending, such as the United States, European nations, and Japan, constitute significant pharmaceutical markets. Due to their strong intellectual property protection, wide market access, and rigorous regulatory frameworks that guarantee safety, effectiveness, and quality standards, these areas provide an advantageous environment for pharmaceutical businesses.

Emerging Trends

The global pharmaceutical business has grown significantly in recent years, playing a crucial role in determining price policies and facilitating access to pharmaceuticals. The expected value of the worldwide pharmaceutical market in 2022 was 1.48tn U.S. dollars, a little rise from the estimated value of the market in 2021 of 1.45tn U.S. dollars.

CrispIdea Outlook

The global pharmaceutical market reached a valuation of US$1.4tn in 2021, and it is projected to expand to ~US$1.8tn by 2026, exhibiting a compound annual growth rate (CAGR) of 3-6%. Excluding the impact of the COVID-19 pandemic, the industry is expected to record a CAGR of around 5% between 2021 and 2026.

Table of Contents

• Executive Summary

• Industry Overview
– Market Overview
– R&D
– Global Trends
– Competitive Landscape and Index

• Segmentation Analysis
– By API Type Analysis
– By Drug Type Analysis
– By Application Analysis

• Outlook

• Key Players
– Pfizer
– Abbvie
– Novartis
– Johnson & Johnson
– Merck & Co
– Sanofi
– Eli Lilly & Company
– Gilead Sciences
– Moderna

Disclaimer

This report was produced by a member company of the Crispidea. This report is for the use of intended recipients only and may not be reproduced (in whole or in part) or delivered or transmitted to any other person without our prior written consent. By accepting this report, the recipient agrees to be bound by the terms and limitations set out herein.

For more Sector Reports

https://www.crispidea.com/report-category/sector-research-reports-industry/

Add Your Heading Text Here

Report details

Pharmaceutical Sector Report 2023 – Addressing health disparities, one innovation at a time

Price

$3,376.00

Company Reports

● EQUITY REPORT
August 28, 2026

Lotus Bakeries NV H1FY26 (LOTB) - Can the €500mn investment drive growth?

● DIVERSIFIED INDUSTRIAL
August 27, 2026

Eaton Corporation plc. (ETN) (Q2FY26) - Transforming portfolio meets near-term leverage

● DIVERSIFIED INDUSTRIAL
August 26, 2026

Oshkosh Corporation Q2FY26 (OSK) - Postal fleet scale anchors growth amid factory retooling

● DIVERSIFIED INDUSTRIAL
August 26, 2026

Caterpillar Inc. (Q2FY26) (CAT) - Multiyear backlog visibility balanced against heavy capital investments

● EQUITY REPORT
August 26, 2026

Fair Isaac Corporation (FICO) (Q3FY26) - Strong pricing meets higher financial leverage

● CONSUMER FINANCIAL SERVICES
August 25, 2026

Visa Inc Q3FY26 (V) - VAS hits 33% of revenue but growth story is priced in

● EQUITY REPORT
August 25, 2026

Teradyne Inc. (TER) (Q2FY26) - Zero debt, record cash and accelerating growth

● EQUITY REPORT
August 25, 2026

Pandora A/S (Q2FY26) (PNDORA) - Platinum potential amid mature market softness

● EQUITY REPORT
August 25, 2026

Amdocs Ltd. (DOX) (Q3FY26) - aOS gains momentum with new deals

● CONSUMER FINANCIAL SERVICES
August 25, 2026

PayPal Holdings, Inc Q2FY26 (PYPL) - Strategic growth progress, but valuation limits upside

● DIVERSIFIED INDUSTRIAL
August 24, 2026

Cummins Inc. (CMI) (Q2FY26) - Power infrastructure demand balances freight headwinds

● EQUITY REPORT
August 23, 2026

Agilent Technologies, Inc (A) (Q2FY26) - Gradual recovery, efficiency gains but headwinds persist

● EQUITY REPORT
August 19, 2026

SAP SE (Q2FY26) (SAPG) - €22.9bn cloud backlog boosts visibility

● EQUITY REPORT
August 19, 2026

International Business Machines (Q2FY26) (IBM) - IBM cuts growth outlook on delays

● EQUITY REPORT
August 13, 2026

Accenture, Plc (ACN) (Q3FY26) - Moving toward non-FTE revenue

● EQUITY REPORT
August 13, 2026

Alphabet, Inc. (GOOGL) (Q2FY26) - Cloud Backlog Reaches Record $514bn

● E-COMMERCE
August 13, 2026

Amazon.com, Inc. (Q2FY26) (AMZN) - AI and AWS fuel growth amid investment pressure

● EQUITY REPORT
August 10, 2026

Qualcomm, Inc. (QCOM) (Q3FY26) - Automotive and AI: Qualcomm's silent engines

● EQUITY REPORT
July 31, 2026

Mondelez International (Q2FY26) (MDLZ) - Emerging markets shine despite input costs

● EQUITY REPORT
July 30, 2026

UiPath Inc. (PATH) (Q1FY27) - Agentic AI challenges traditional RPA

Sector Reports

Silicon Platform as a Service (SiPaaS) - 2026
September 30, 2026 ● SECTOR REPORTS

Silicon Platform as a Service (SiPaaS) - 2026

The Wealth Technology Report - 2026
September 22, 2026 ● SECTOR REPORTS

The Wealth Technology Report - 2026

The Streaming Market Outlook - 2026
September 16, 2026 ● SECTOR REPORTS

The Streaming Market Outlook - 2026

The Quick Commerce Report - 2026
September 9, 2026 ● SECTOR REPORTS

The Quick Commerce Report - 2026

The Quantum Security-Resilience Beyond Q-Day
August 17, 2026 ● SECTOR REPORTS

The Quantum Security-Resilience Beyond Q-Day

Global Power Investment Report - 2026
August 5, 2026 ● SECTOR REPORTS

Global Power Investment Report - 2026

"ANTIQ" 1H26: THE COLLECTIVE SEMICONDUCTOR STOCK PERFORMANCE
July 15, 2026 ● SECTOR REPORTS

"ANTIQ" 1H26: THE COLLECTIVE SEMICONDUCTOR STOCK PERFORMANCE

Tokenization: Turning Real-World Value into Digital Opportunity
July 1, 2026 ● SECTOR REPORTS

Tokenization: Turning Real-World Value into Digital Opportunity

Shopping Cart
No products in the cart.
Add Order Note
Estimate Shipping